Paper26344467
Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.
Li W and 2 others. Vaccines (Basel), 2013. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. Papers, record 26344467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 AI078073 | NIAID NIH HHS | United States | U01AI078073 | PubMed |
Source NIH RePORTER
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16987975 | Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. | J Virol | 2006 | https://conductscience.org/library/papers/16987975 | PubMed |
| 2 | 22094541 | Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis. | Int Immunopharmacol | 2012 | https://conductscience.org/library/papers/22094541 | PubMed |
| 3 | 18538900 | Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. | Vaccine | 2008 | https://conductscience.org/library/papers/18538900 | PubMed |
| 4 | 21760928 | Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. | PLoS One | 2011 | https://conductscience.org/library/papers/21760928 | PubMed |
| 5 | 18724414 | Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. | Vaccine | 2008 | https://conductscience.org/library/papers/18724414 | PubMed |
| 6 | 15908389 | Human immune response to a plague vaccine comprising recombinant F1 and V antigens. | Infect Immun | 2005 | https://conductscience.org/library/papers/15908389 | PubMed |
| 7 | 21199697 | Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge. | Vaccine | 2011 | https://conductscience.org/library/papers/21199697 | PubMed |
| 8 | 20188257 | Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines. | Vaccine | 2010 | https://conductscience.org/library/papers/20188257 | PubMed |
| 9 | 21975270 | DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. | Lancet Infect Dis | 2011 | https://conductscience.org/library/papers/21975270 | PubMed |
| 10 | 10717537 | Current epidemiology of human plague in Madagascar. | Microbes Infect | 2000 | https://conductscience.org/library/papers/10717537 | PubMed |
| 11 | 16325880 | Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine. | Virology | 2006 | https://conductscience.org/library/papers/16325880 | PubMed |
| 12 | 21085486 | Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies. | PLoS One | 2010 | https://conductscience.org/library/papers/21085486 | PubMed |
| 13 | 15011977 | Yersinia pestis: still a plague in the 21st century. | Clin Lab Sci | 2004 | https://conductscience.org/library/papers/15011977 | PubMed |
| 14 | 19500964 | Heterologous prime-boost vaccination. | Curr Opin Immunol | 2009 | https://conductscience.org/library/papers/19500964 | PubMed |
| 15 | 20170767 | Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. | Vaccine | 2010 | https://conductscience.org/library/papers/20170767 | PubMed |
| 16 | 15919951 | Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1. | J Virol | 2005 | https://conductscience.org/library/papers/15919951 | PubMed |
| 17 | 15174978 | Yersinia pestis (plague) vaccines. | Expert Opin Biol Ther | 2004 | https://conductscience.org/library/papers/15174978 | PubMed |
| 18 | 9269050 | A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. | Vaccine | 1997 | https://conductscience.org/library/papers/9269050 | PubMed |
| 19 | 19943765 | Prospects for new plague vaccines. | Expert Rev Vaccines | 2009 | https://conductscience.org/library/papers/19943765 | PubMed |
| 20 | 15308359 | A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. | Vaccine | 2004 | https://conductscience.org/library/papers/15308359 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40529698 | Biological threat preparedness through vaccine development and stockpiling: challenges and strategic implications. | Front Public Health | 2025 | https://conductscience.org/library/papers/40529698 | PubMed |
| 34142207 | Plague vaccines: new developments in an ongoing search. | Appl Microbiol Biotechnol | 2021 | https://conductscience.org/library/papers/34142207 | PubMed |
| 30898066 | Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics. | MAbs | 2019 | https://conductscience.org/library/papers/30898066 | PubMed |
| 30328017 | Recombinant neuraminidase pseudotyped baculovirus: a dual vector for delivery of Angiotensin II peptides and DNA vaccine. | AMB Express | 2018 | https://conductscience.org/library/papers/30328017 | PubMed |
| 29456657 | Intramuscular primary immunization by nucleic acid vaccine pcDNA/Gpd-IL-2 and enhanced immunization with mucosal adjuvant CpG-ODN and Gpd-IL-2 recombinant protein effectively induced strong mucosal immune responses and immune protective effects against Treponema pallidum skin infection. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29456657 | PubMed |
| 28956354 | Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice. | J Microbiol | 2017 | https://conductscience.org/library/papers/28956354 | PubMed |
| 27048742 | DNA immunization as a technology platform for monoclonal antibody induction. | Emerg Microbes Infect | 2016 | https://conductscience.org/library/papers/27048742 | PubMed |
| 25488991 | Identification of Aim2 as a sensor for DNA vaccines. | J Immunol | 2015 | https://conductscience.org/library/papers/25488991 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26344467
GET https://conductscience.org/api/papers/v1/26344467/references?page=2